Skip to main content

Day: June 9, 2022

IMG Academy Expands Partnership with PlaySight, Bringing Connected Camera Sports Technology Platform to Tennis Facilities

Connexa Sports Technologies Inc. Connexa Sports Expands Partnership With IMG AcademyConnexa Sports secures a key partnership in its flagship sport of tennis; PlaySight’s industry-standard video tech will drive live streaming and performance tech capabilities on all 55 tennis courts BALTIMORE, June 09, 2022 (GLOBE NEWSWIRE) — Connexa Sports Technologies Inc. (OTCQB: CNXA) (www.connexasports.com) is pleased to announce that its wholly owned subsidiary, PlaySight Interactive (www.playsight.com) is expanding its partnership with the world-renowned IMG Academy. PlaySight first partnered with IMG Academy back in 2020 through its baseball program, who rely on PlaySight’s pioneering sports technology platform for live streaming, remote scouting, and recruiting, as well as player performance and film breakdowns. With the expansion to...

Continue reading

XR Immersive Tech Announces Partnership with QuarkXR For Industry First VR Streaming Solution

VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — XR Immersive Tech Inc. (“Immersive Tech”, or the “Company”) (CSE:VRAR) (FSE:79W) (OTCQB: FNTTF) is pleased to announce that the Company’s recently acquired subsidiary, SynthesisVR Inc. (“Synthesis VR”), a leading location-based virtual reality (“LBVR”) content distribution and facility management platform, has released its new VR streaming product to VR arcades worldwide through a co-development partnership with QuarkXR, a pioneering company focused on VR streaming and a trusted solution provider for companies like Deutsche Telekom, Orange, Vodafone, and Ericsson, among others. The SynthesisVR / QuarkXR streaming product offers all Location-based VR (LBVR) arcade operators a simple, and automated VR streaming solution, previously not available in the market. A solution...

Continue reading

Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program

Favorable tolerability with no grade 3/4 neutropenia and encouraging anti-tumor activity across Phase 1b monotherapy expansion Combinability with CDK4/6i palbociclib demonstrated across initial dose escalation cohorts, including no dose limiting toxicities and no induced metabolism of palbociclib Rapidly advancing the development of OP-1250 for ER+ / HER2- breast cancer with pivotal monotherapy study planned for 2023 initiationSAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) today announced clinical development progress for OP-1250, a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD) in development for the treatment of metastatic breast cancer. “We are extremely pleased with the emerging clinical profile of OP-1250 and...

Continue reading

Salarius Pharmaceuticals to Participate in BIO International Convention 2022

HOUSTON, Texas, June 09, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options, today announced that the Company will participate in the 2022 BIO International Convention in San Diego from June 13-16, 2022. During the conference, attended by over 15,000 industry leaders, members of the Salarius team will provide updates on its two drug candidates, the Targeted Protein Degrader SP-3164 and the Protein Inhibitor seclidemstat. SP-3164 is a next-generation targeted protein degrader that induces selective elimination of cancer-causing proteins and is being investigated by Salarius as a potential treatment for hematological cancers and solid tumors. Seclidemstat is Salarius’ lead clinical candidate, which...

Continue reading

Form 8.3 – [LXI REIT PLC 08 06 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXI REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

MULTICHOICE DELIVERS STEADY MARGINS DESPITE CONTENT COST NORMALISATION

MultiChoice Factsheet MultiChoice FY22 Financial Results FactsheetCalvo Mawela Calvo Mawela, MultiChoice Group CEOJohannesburg, June 09, 2022 (GLOBE NEWSWIRE) — Johannesburg – South Africa, 9 June 2022: MultiChoice Group (MCG, or the group), Africa’s leading entertainment company, delivered steady margins for the year ended 31 March 2022 (FY22). “Reduced losses in the Rest of Africa (RoA), a rebound in advertising revenues and a continued focus on cost containment enabled us to absorb the R1.1bn impact of a normalisation in content costs as live sport returned and we resumed our local content production post the COVID-19 lockdowns,” says Calvo Mawela, Chief Executive Officer.  “We continued to enhance our video entertainment offering and expanded the variety of services offered to our customers as we grow our entertainment...

Continue reading

Form 8.3 – [IDEAGEN PLC 08 06 2022] – CGWL

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Clip Money, Inc. to Host Live Corporate Webinar on June 16th at 11am ET

Joseph Arrage, Co-Founder & CEO of Clip Money, will provide a corporate overview via a live presentation followed by live Q&A Investors and other interested parties are invited to join and learn more about Clip Money’s cloud-based platform for faster and easier banking transactions.TORONTO, June 09, 2022 (GLOBE NEWSWIRE) — Clip Money Inc. (TSXV: CLIP) (formerly 13842053 Canada Corp.) (“Clip Money”, or the “Company”) is pleased to announce that the Company’s Co-Founder & CEO, Joseph Arrage, will be presenting Clip Money’s story, including an overview of current operations and upcoming milestones, while sharing our most recent Investor Presentation. We invite all investors and other interested parties to register for the webinar at the link below. Date: Thursday, June 16, 2022Time: 11am ETRegister: Webinar Registration HAVE...

Continue reading

Form 8.3 – [BIFFA PLC 08 06 2022] – CGWM

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree BIFFA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

UPDATE — NIO Inc. Reports Unaudited First Quarter 2022 Financial Results

Quarterly Total Revenues reached RMB9,910.6 million (US$1,563.4 million)iQuarterly Deliveries of the ES8, the ES6, the EC6 and the ET7 were 25,768 vehicles SHANGHAI, China, June 09, 2022 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced its unaudited financial results for the first quarter ended March 31, 2022. Operating Highlights for the First Quarter of 2022Deliveries of vehicles were 25,768 in the first quarter of 2022, including 4,341 ES8s, 13,620 ES6s, 7,644 EC6s and 163 ET7s, representing an increase of 28.5% from the first quarter of 2021 and an increase of 2.9% from the fourth quarter of 2021.       Key Operating Results              2022 Q1 2021 Q4 2021 Q3 2021 Q2Deliveries 25,768 25,034 24,439 21,896           2021...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.